Related Experiment Videos
Echinomycin inhibits chromosomal DNA replication and embryonic development in vertebrates
Laurence G May1, Mark A Madine, Michael J Waring
1Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK.
Nucleic Acids Research
|January 6, 2004
Summary
Echinomycin, a quinoxaline antibiotic, blocks DNA replication by binding to double-helical DNA. This inhibition occurs before transcription, suggesting anti-proliferative effects via DNA replication interference.
Area of Science:
- Molecular Biology
- Cell Biology
- Pharmacology
Background:
- Echinomycin is a quinoxaline antibiotic known to inhibit RNA synthesis.
- Its mechanism is linked to binding double-helical DNA.
Purpose of the Study:
- Investigate echinomycin's effect on DNA replication.
- Utilize Xenopus laevis egg extracts/embryos and human cells.
Main Methods:
- In vitro studies with Xenopus sperm chromatin and HeLa cell nuclei.
- Experiments in HeLa cells and X. laevis embryos.
- Assessing effects on chromatin decondensation, nuclear assembly, and DNA replication.
Main Results:
- Echinomycin inhibits DNA replication, but not single-stranded DNA replication.
- The drug interferes with chromatin decondensation and nuclear assembly.
- Echinomycin causes anaphase bridges and cell death in treated cells and embryos.
- Inhibition of DNA replication precedes transcription in early Xenopus embryos.
Conclusions:
- Echinomycin specifically targets chromosomal DNA replication.
- Quinoxaline antibiotics may have anti-proliferative effects by inhibiting DNA replication.
- Echinomycin's action is on DNA, not replication proteins.